Position in ALT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,221,450
+$2,197,284 QoQ
Shares Held
1,045,926
+268.7% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 89.76533712710078.ToString("F0")%
Shared 4.852924585486927.ToString("F0")%
None 5.381738287412303.ToString("F0")%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. ALT ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ALT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,221,450 | 1,045,926 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,024,166 | 283,703 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,122,662 | 297,789 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,731,706 | 447,470 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,462,345 | 492,469 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,567,107 | 633,441 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,968,753 | 646,377 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,791,656 | 570,174 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,389,550 | 234,730 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,942,076 | 261,518 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $492,051 | 189,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $904,575 | 256,254 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,390,632 | 566,501 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,925,878 | 177,865 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,226,743 | 174,373 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,443,358 | 123,364 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $442,755 | 72,702 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $718,785 | 78,470 | Shares | Defined | 2022-02-09 | |
| 2020-09-30 | $638,246 | 48,352 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $517,849 | 48,352 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $155,209 | 48,352 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||